Related references
Note: Only part of the references are listed.Satisfaction With and Confidence in Needle-Free Subcutaneous Sumatriptan in Patients Currently Treated with Triptans
Roger K. Cady et al.
HEADACHE (2011)
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment
Anna Ferrari et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Injection Anxiety Remains a Long-term Barrier to Medication Adherence in Multiple Sclerosis
Aaron P. Turner et al.
REHABILITATION PSYCHOLOGY (2009)
How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians
RB Lipton et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Triptan nonresponder studies: Implications for clinical practice
DW Dodick
HEADACHE (2005)
Pharmacological treatments for acute migraine: quantitative systematic review
AD Oldman et al.
PAIN (2002)
Triptans in migraine - A comparative review of pharmacology, pharmacokinetics and efficacy
P Tfelt-Hansen et al.
DRUGS (2000)
Share Paper
